PEPTID-OLIGONUKLEOTIDKONJUGATE

Patent europeic · EP3297649 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3297649
Numer da la dumonda
EP16797300
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-05-2016
Publitgà
28-03-2018
Concedì
11-10-2023
La protecziun finescha il pli tard
18-05-2036
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61K 38/16 (2006.01)
C07K 16/00 (2006.01)
Prioritad
US 201562163960 P 19.05.2015
US 201662337536 P 17.05.2016
Dumonda PCT
PCT/US2016/033276 19.05.2016
Publicaziun PCT
WO2016/187425 24.11.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 21-08-2024

    Midada

    Published in Swissreg on 21.08.2024

  4. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  5. 11-10-2023

    Concedì

    Published in Swissreg on 11.10.2023

Partidas

Possessur

Sarepta Therapeutics, Inc.

215 First Street, Cambridge, MA 02142, US

Inventur

HANSON, Gunnar J.

Cambridge, Massachusetts 02142, US

ZHOU, Ming

Cambridge, Massachusetts 02142, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.